|
|
|
|
Tuesday, April 14, 2009
|
|
|
|
|
|
U.K. RAPID REVIEW PANEL GIVES KIMBERLY-CLARK* INTEGUSEAL* RECOMMENDATION 1
(LONDON, 14 April 2009) InteguSeal* Microbial Sealant from Kimberly-Clark Health Care has been given ‘recommendation 1’ by the Department of Health’s Rapid Review Panel (RRP)
In the findings published on the Health Protection Agency’s website www.hpa.org.uk for InteguSeal* the RRP said: “Basic research and development, validation and recent in use evaluations have shown benefits that should be available to NHS bodies to include as appropriate in their cleaning hygiene or infection control protocols.”
Additional information published by the panel provides a summary of how InteguSeal* works. It said: “This product is a barrier, intended to prevent intraoperative contamination of surgical incisions. Following skin disinfection, it is applied as a liquid and then seals the skin around the operative site, preventing wound contamination from the surrounding skin microflora whilst allowing normal transpiration of water vapour.” The web link detailing the recommendation is www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1232957471552
Information about InteguSeal* can also be found on the NHS Clean, Safe Care website www.clean-safe-care.nhs.uk , a hub for information, tools and news about reducing healthcare associated infections (HCAI) and providing safe, clean, reliable healthcare. The links are http://www.clean-safe-care.nhs.uk/index.php?pid=69 and
http://www.clean-safe-care.nhs.uk/Documents/KC_InteguSeal_template.pdf
The RRP has been set up to provide the Department of Health with prompt assessment of new and novel products or protocols designed to reduce HCAI.
To date, InteguSeal* has been used in more than 150,000 applications during surgical procedures across the world. Clinical studies have shown that InteguSeal* reduces surgical wound bacterial contamination when used in conjunction with standard skin preparation (1) and its use in surgery can significantly reduce the Surgical Site Infection rates (2). Further studies have also revealed that the decrease in infection rates also saves hospitals money for extended treatment (3).
Dr Lynne Kelley, Vice President Medical Director for Kimberly-Clark Healthcare said: “Kimberly Clark Health Care is committed to partnering with hospitals to help reduce healthcare associated infections and, where possible, bring new and novel technology to the marketplace. Many years of research and development and clinical testing have been invested into InteguSeal* and it is very satisfying for all involved to achieve a recommendation 1 from the Rapid Review Panel.”
References
1. Towfigh S, Cheadle W, Lowry S, Malongoni M, Wilson S. Significant reduction in incidence of wound contamination by skin flora through use of microbial sealant. Archives of Surgery Vol 43 (No.9) September 2008
2. Dohmen PM, Gabbieri D, Weymann A, Linneweber J, Konertz W. A preliminary study of patients undergoing cardiovascular surgery to prevent surgical site infections. European Society for CardioVascular Surgery (ESCVS) April 2008
3. Dohmen PM, Gabbieri D, Weymann A, Linneweber J, Konertz W. What’s the impact of InteguSeal* on surgical site infections reduction and are there any economical benefits? 38th Annual Meeting of the German Society for Thoracic and Cardiovascular Surgery, February 2009
|
|
|
|